Presentation schedule



Click on the links below to view abstracts and posters presented at this congress. All copyright remains that of the copyright holder. This page will be available for a limited period after the congress.

Oral presentations
Tuesday 17 September 2019

OP 03 Addressing limitations of insulin therapy  Ochoa Hall

OP 09 Semaglutide: ingested or injected  Ochoa Hall

2:45 PM–3:00 PM

Oral presentation 50 Dahl

Oral semaglutide improves postprandial glucose and lipid metabolism and delays first-hour gastric emptying in subjects with type 2 diabetes

  View PDF

3:00 PM–3:15 PM

Oral presentation 51 Meier

Efficacy of oral semaglutide according to baseline HbA1c: an exploratory subgroup analysis of the PIONEER trial programmee

  View PDF

3:15 PM–3:30 PM

Oral presentation 52 Lingvay

Once-weekly semaglutide vs. canagliflozin in type 2 diabetes: results of the SUSTAIN 8 trial

  View PDF

3:30 PM–3:45 PM

Oral presentation 54 McCrimmon

Effects of once-weekly semaglutide vs. canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 trial

  View PDF

3:45 PM–4:00 PM

Oral presentation 53 Capehorn

Efficacy and safety of semaglutide 1.0 mg once weekly vs. liraglutide 1.2 mg once daily as add-on to 1–3 oral glucose-lowering drugs in subjects with type 2 diabetes (SUSTAIN 10)

  View PDF